KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Manhattan Associates (MANH) Cash from Operations (2016 - 2025)

Historic Cash from Operations for Manhattan Associates (MANH) over the last 17 years, with Q3 2025 value amounting to $93.1 million.

  • Manhattan Associates' Cash from Operations rose 4945.67% to $93.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $347.1 million, marking a year-over-year increase of 2456.99%. This contributed to the annual value of $295.0 million for FY2024, which is 1981.37% up from last year.
  • Per Manhattan Associates' latest filing, its Cash from Operations stood at $93.1 million for Q3 2025, which was up 4945.67% from $74.0 million recorded in Q2 2025.
  • Over the past 5 years, Manhattan Associates' Cash from Operations peaked at $104.7 million during Q4 2024, and registered a low of $31.8 million during Q1 2022.
  • Moreover, its 5-year median value for Cash from Operations was $58.6 million (2023), whereas its average is $60.4 million.
  • Its Cash from Operations has fluctuated over the past 5 years, first soared by 24419.23% in 2021, then tumbled by 3311.55% in 2022.
  • Manhattan Associates' Cash from Operations (Quarter) stood at $40.1 million in 2021, then soared by 37.72% to $55.2 million in 2022, then soared by 59.99% to $88.4 million in 2023, then increased by 18.5% to $104.7 million in 2024, then fell by 11.07% to $93.1 million in 2025.
  • Its Cash from Operations was $93.1 million in Q3 2025, compared to $74.0 million in Q2 2025 and $75.3 million in Q1 2025.